Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.

‘Inferior efficacy’ leads to premature end of PhIII for Bayer’s next-gen blood thinner asundexian

Bayer is bringing a Phase III trial for its blood thinner asundexian to an early end after the drug showed “inferior efficacy” against the control

November 21, 2023

Older adults’ social patterns shift post-pandemic, study finds

Years after the U.S. began to slowly emerge from mandatory COVID-19 lockdowns, more than half of older adults still spend more time at home and

April 11, 2024

IG Live August 21: When There’s No ‘Next Round’ of Chemo Available

Although drug shortages are not uncommon, the scale of the current chemotherapy drug shortage is especially widespread, potentially affecting up to half a million Americans.

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.